By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today said it has entered into purchase agreements with investors to raise more than $7.8 million.

The agreement is for a private placement of 5.3 million new shares of its common stock priced at $1.50 per share. The financing comes from mostly new investors, the Los Angeles-based molecular diagnostics firm said, with existing investors, board members, and senior management also participating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.